Sigmapharm Laboratories, LLC drugs
7 results
Acitretin (acitretin)
(ACITRETIN)Sigmapharm Laboratories, LLC
Usage: Acitretin Capsules, USP are indicated for the treatment of severe psoriasis in adults. They should only be prescribed by those skilled in systemic retinoid use, especially for non-pregnant females of reproductive potential unresponsive to other therapies, due to significant adverse effects and potential birth defects.
Adefovir dipivoxil (adefovir dipivoxil)
(ADEFOVIR DIPIVOXIL)Sigmapharm Laboratories, LLC
Usage: Adefovir Dipivoxil Tablets are indicated for treating chronic hepatitis B in patients aged 12 and older with active viral replication and elevated serum aminotransferases or histologically active disease. This includes cases with lamivudine-resistant hepatitis B virus in both compensated and decompensated liver function.
Ergocalciferol (ergocalciferol)
(Ergocalciferol)SigmaPharm Laboratories, LLC
Usage: Ergocalciferol capsules are indicated for treating hypoparathyroidism, refractory rickets (vitamin D resistant rickets), and familial hypophosphatemia.
Nitroglycerin (nitroglycerin)
(NITROGLYCERIN)Sigmapharm Laboratories, LLC
Usage: Nitroglycerin sublingual tablets are indicated for the acute relief of angina pectoris and for acute prophylaxis in patients with coronary artery disease.
Potassium chloride (potassium chloride)
(POTASSIUM CHLORIDE)Sigmapharm Laboratories, LLC
Usage: Potassium chloride extended-release tablets are indicated for treating and preventing hypokalemia, with or without metabolic alkalosis, in patients who cannot manage their potassium levels through diet or reduction of diuretic doses.
Protriptyline hydrochloride (protriptyline hydrochloride)
(Protriptyline Hydrochloride)Sigmapharm Laboratories, LLC
Usage: Protriptyline hydrochloride tablets are indicated for treating symptoms of mental depression, especially in patients who are withdrawn or anergic, and should be used under close medical supervision.
Ticagrelor (ticagrelor)
(TICAGRELOR)Sigmapharm Laboratories, LLC
Usage: Ticagrelor tablets are indicated to reduce cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. They also decrease stent thrombosis rates in patients treated with stents for acute coronary syndrome, demonstrating superiority over clopidogrel for at least 12 months.